Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates

Tuberculosis

Volumn 92, Issue 5, 2012, Pages 404-406

  Jain, Amita ^a   Dixit, Pratima ^a   Prasad, Rajendra ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Drug resistance; M. tuberculosis; MDR TB; Pre XDR TB; XDR TB

Indexed keywords

ETHAMBUTOL; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INDIA; KANAMYCIN; KANAMYCIN RESISTANCE; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; POPULATION SURVEILLANCE; PREVALENCE; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84865478464     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2012.05.010     Document Type: Article

References (26)

1. World Health Organization. Report of the meeting of the WHO Global Task Force on XDR-TB. Geneva, Switzerland, 9-10 October 2006. WHO/HTM/TB/2007.375. Geneva, Switzerland: WHO; 2007.
2. World Health Organization Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response 2010 World Health Organization WHO/HTM/TB/2010.3
3. R. Banerjee, J. Allen, J. Westenhouse, P. Oh, W. Elms, and E. Desmond Extensively drug -resistant tuberculosis in California, 1993-2006 Clin Infect Dis 47 2008 450 457
4. M. Zhao, X. Li, P. Xu, X. Shen, X. Gui, and L. Wang Transmission of MDR and XDR tuberculosis in Shanghai, China PLoS One 4 2 2009 e4370
5. E.R. Grimaldo, T.E. Tupasi, A.B. Rivera, M.I. Quelapio, R.C. Cardaño, and J.O. Derilo Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant Mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines Int J Tuberc Lung Dis 5 2001 546 550 (Pubitemid 32587285)
6. C.N. Paramasivan, F. Rehman, F. Wares, N. Sundar Mohan, S. Sundar, and S. Devi First- and second-line drug resistance patterns among previously treated tuberculosis patients in India Int J Tuberc Lung Dis 14 2 2010 243 246
7. Revised National Tuberculosis Control Programme (RNTCP). Manual for laboratory technician. New Delhi: Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare.
8. Revised National TB Control Programme Training Manual for Mycobacterium tuberculosis Culture & Drug susceptibility testing April 2009 Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi 110011.
9. G.P. Kubica Differential identification of mycobacteria. VII. Key to features for identification of clinically significant mycobacteria Am Rev Respir Dis 107 1973 9 21
10. Revised National TB Control Programme Training Manual for Mycobacterium tuberculosis Culture & Drug susceptibility testing April 2009 Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi- 110011.
11. Guidelines for drug susceptibility testing for second line anti tuberculosis drugs for DOTS-PLUS. Communicable Diseases WHO/CDS/TB/2001.288.
12. R. Ramachandran, S. Nalini, V. Chandrasekar, P.V. Dave, A.S. Sanghvi, and F. Wares Surveillance of drug-resistant tuberculosis in the state of Gujarat, India Int J Tuberc Lung Dis 13 9 2009 1154 1160
13. M. Hanif, S. Malik, and V.K. Dhingra Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi India Int J Tuberc Lung Dis 13 1 2009 74 78
14. S.K. Sharma, N. George, T. Kadhiravan, P.K. Saha, H.K. Mishra, and M. Hanif Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study Indian J Med Res 130 4 2009 392 395
15. D. Wang, C. Yang, T. Kuang, H. Lei, X. Meng, and A. Tong Prevalence of multidrug and extensively drug resistant tuberculosis in Beijing, China: a hospital -based retrospective study Jpn J Infect Dis 63 2010 368 371
16. C.K. Mlambo, R.M. Warren, X. Poswa, T.C. Victor, A.G. Duse, and E. Marias Genotypic diversity of extensively drug resistant tuberculosis (XDR-TB) in South Africa Int J Tuberc Lung Dis 12 2008 99 104
17. L. Jugheli, L. Rigouts, I.C. Shamputa, Rijk W. Bram de, and F. Portaels High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia Int J Tuberc Lung Dis 12 5 2008 561 566 (Pubitemid 351703064)
18. K.M. Kam, and W. Yip Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after implementation of DOTS-Plus Int J Tuberc Lung Dis 8 6 2004 760 766 (Pubitemid 38747153)
19. Y. Balabanova, M. Ruddy, J. Hubb, M. Yates, N. Malomanova, and I. Fedorin Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second line drug resistance and development of standardized therapy Eur J Clin Microbiol Infect Dis 24 2005 136 139 (Pubitemid 40487382)
20. T.S. Huang, C.M. Kunin, S.S.J. Lee, Y.S. Chen, H.Z. Tu, and Y.C. Liu Trends in floroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003 J Antimicrobiol Chemother 53 2003 1058 1062 (Pubitemid 43009820)
21. M. Kozińska, A. Brzostek, D. Krawiecka, M. Rybczyńska, Z. Zwolska, and E.M.D.R. Augustynowicz-Kopeć Pre-XDR and XDR drug-resistant tuberculosis in Poland in 2000-2009 Pneumonol Alergol Pol 79 4 2011 278 287
22. D.H. Kim, H.J. Kim, S.K. Park, S.J. Kong, Y.S. Kim, T.H. Kim, E.K. Kim, K.M. Lee, S.S. Lee, J.S. Park, W.J. Koh, C.H. Lee, and T.S. Shim Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis Am J Respir Crit Care Med 182 1 2010 113 119
23. S. Blower, and V. Supervie Predicting the future of XDR tuberculosis Lancet Infect Dis 7 2007 443 (Pubitemid 46962341)
24. Centers for Disease Control and Prevention (CDC) Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004 Morb Mortal Wkly Rep 55 2006 301 305
25. A. Valayati, and M. Masjedi Emergence of new forms of totally drug resistant tuberculosis bacilli Chest 136 2009 420 425
26. J.Y. Wang, P.R. Hsueh, I.S. Jan, L.N. Lee, Y.S. Liaw, and P.C. Yang Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas Thorax 61 10 2006 903 908